Apogee Therapeutics
$84.48
20
+$0.31+0.37% Today
Statistics
Day High
85.94
Day Low
84.06
52W High
85.94
52W Low
26.2
Volume
258,223
Avg. Volume
1,103,555
Mkt Cap
5.87B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-1.087153
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-511.69MNet Income
Analyst Ratings
$111.73Average Price Target
The highest estimate is 160.00.
From 12 ratings within the last 6 months. This is not an investment recommendation.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy 75%
Hold 25%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow APGE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Show more...
CEO
Dr. Michael Thomas Henderson M.D.
Employees
196
Country
US
ISIN
US03770N1019
Listings
0 Comments
Share your thoughts
FAQ
What is Apogee Therapeutics stock price today?▼
The current price of APGE is $84.48 USD — it has increased by +0.37% in the past 24 hours. Watch Apogee Therapeutics stock price performance more closely on the chart.
What is Apogee Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Apogee Therapeutics stocks are traded under the ticker APGE.
Is Apogee Therapeutics stock price growing?▼
APGE stock has risen by +7.47% compared to the previous week, the month change is a +20.57% rise, over the last year Apogee Therapeutics has showed a +137.01% increase.
What is Apogee Therapeutics market cap?▼
Today Apogee Therapeutics has the market capitalization of 5.87B
When is the next Apogee Therapeutics earnings date?▼
Apogee Therapeutics is going to release the next earnings report on May 18, 2026.
What were Apogee Therapeutics earnings last quarter?▼
APGE earnings for the last quarter are -1.03 USD per share, whereas the estimation was -1.04 USD resulting in a +1.4% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Apogee Therapeutics revenue for the last year?▼
Apogee Therapeutics revenue for the last year amounts to 0 USD.
What is Apogee Therapeutics net income for the last year?▼
APGE net income for the last year is -511.69M USD.
How many employees does Apogee Therapeutics have?▼
As of April 01, 2026, the company has 196 employees.
In which sector is Apogee Therapeutics located?▼
Apogee Therapeutics operates in the Health Care sector.
When did Apogee Therapeutics complete a stock split?▼
The last stock split for Apogee Therapeutics was on January 08, 2008 with a ratio of 1:50.
Where is Apogee Therapeutics headquartered?▼
Apogee Therapeutics is headquartered in Waltham, US.